Having trouble viewing this message? View this email in a browser.
Share Share
Tweet Tweet
Forward Forward

What Do You Need to Know About the Coronavirus?

The coronavirus (COVID-19) has a lot of people concerned. But there's something people with asthma in the U.S. should be even more concerned about right now - the flu. Read about risks, prevention and what to do if you get sick.

Is it a Cold or Is It Allergies?

The two can have similar symptoms but require different treatments. And they are both more likely to occur during the same time of year. Learn the difference.

4 Things You Must Know About the Flu If You Have Asthma

Up to 41 million people or more have had the flu this season, and activity is still high. If you have asthma and get the flu, you are at high risk for complications. Find out what you need to know about the flu to stay healthy.

Announcing the First CERTIFIED Crib Mattress

Pure Zees' baby mattress is the first infant mattress to become CERTIFIED asthma & allergy friendly®. This means it has been scientifically tested to ensure it can create a healthier sleeping environment for your baby. Read more.


It is easier to manage asthma and allergies with encouraging support. When you donate to AAFA, you give people access to life-saving education. You help connect people managing the same conditions for peer support. And you advocate for better protections for people with asthma and allergies.

You can be part of our mission that makes a difference in the lives of people with asthma and allergies. Will you donate $35 or $50 today?


FDA Approves a Generic Version of ProAir

A generic version of ProAir HFA, a quick-relief inhaler that contains albuterol, could be available soon, thanks to approval from the U.S. Food and Drug Administration (FDA). Learn more.

Follow AAFA's Blog for Research Updates

AAFA will be attending and exhibiting at the 2020 Annual Meeting of the American Academy of Asthma Allergy Immunology in March. This year's theme is New Paradigms in the Management of Allergic Disease - A Focus on Biologics.

FDA Is Reviewing Dupilumab for Ages 6-11 With Moderate-to-Severe Atopic Dermatitis

The biologic dupilumab received priority review status for this use by the FDA. Learn what this could mean for children with atopic dermatitis (eczema).


The Asthma and Allergy Foundation of America (AAFA) needs your help as we plan our first-ever patient and family conference! If you or your family are impacted by asthma, allergies, eczema or related conditions, we’d love to hear from you.

Thank you for your continued support.

Follow Follow
Twitter Twitter
Instagram Instagram
Disclaimer: This newsletter is provided to you as a member and subscriber benefit and your use of it is in accordance with our website's terms of service.

Asthma and Allergy Foundation of America makes no representation, whatsoever, for the contents that may be contained in any of the sponsors or advertisers in this newsletter or the quality of any products, information, or other materials displayed, purchased or obtained by you as a result of an offer in connection with any advertisement. Please follow the instructions at the bottom of the newsletter to unsubscribe if you no longer wish to be on our newsletter mailing list. This newsletter is sent to all newsletter subscribers, registered members and donors of Asthma and Allergy Foundation of America.

Copyright © 2020 Asthma and Allergy Foundation of America, All rights reserved. ISSN 1939-8166.